Radiation Oncology Market Growth and Trends

Rising Prevalence of Cancer Is the Prime Factor Responsible for Extensive Growth Of Radiation Oncology Market Till 2025

“The global radiation oncology market size was valued at USD 5.7 billion in 2016 and is expected to grow at a CAGR of 6.5% Till 2025�

The global Radiation Oncology Market is expected to reach USD 10.1 billion by 2025, according to a new report by Grand View Research, Inc. Rising prevalence of cancer is the prime factor responsible for substantial growth of radiation oncology market over the forecast period.

Access Full Research Report on Global Radiation Oncology Market: http://www.grandviewresearch.com/industry-analysis/radiation-oncology-market Technological advancements in radiotherapy resulted in increased adoption of radiation oncology as primary treatment line of cancer. Development of compact advanced radiotherapy options such as CyberKnife, Gamma Knife, and tomotherapy complemented this growth. These advanced methods pose lesser postoperative complications and faster recovery time.

Increasing per capita healthcare expenditure is also an important macroeconomic factor driving the market growth. In addition, with the aid of supportive government initiatives

Follow Us:

and awareness, patients are not hesitant to opt for advanced treatment options. For instance, per capita health expenditure witnessed exponential growth of more than 55.0% from 1995 to 2014, as stated by the World Bank Group.

Further key findings from the study suggest: 

External Beam Radiation Therapy (EBRT) inclusive of compact advanced radiation therapy, proton therapy, and Linear Accelerator (LINAC), held lucrative share in the product segment of radiation oncology market in 2016.



Brachytherapy is likely to gain maximum share over the next eight years. Extensive usage of brachytherapy for the treatment of prostate and breast cancer is anticipated to govern the growth.



EBRT applications inclusive of prostate treatment, breast, lung, colorectal, head, and neck cancer dominated application segment.



Image Guided Radiation Therapy (IGRT) contributed to technology with around 13.0% share in 2016. In this method, overall objective is to minimize the exposure to the healthy surrounding tissue.



3-D CRT technology is anticipated to grow at a lucrative growth rate over the next 8 years. In this technique, radiation beams form the shape at the specific site of cancer.



North America held maximum share in global radiation oncology market in 2016.

Developed health infrastructure, presence of many multinational players, and greater per capita health infrastructure are the key factors contributing to the dominance of this region over the forecast period.



However, uncertain health reforms post the U.S. presidential election of 2016 coupled with shortage in supply of radiopharmaceuticals is likely to hinder the growth in this region.



Varian Medical Systems, Elekta AB, Accuray Incorporated, Ion Beam Applications SA, C.R. Bard, Inc., IsoRay, Inc., Mevion Medical Systems, Nordion (Canada) Inc.,

Follow Us:

NTP, and Mallinckrodt Public Limited Company are some of the key players operating in radiation oncology market.

Grand View Research has segmented the Radiation Oncology Market by product, application, technology, and region: Read Our Blogs on Reports from this category By Grand View Research: http://www.grandviewresearch.com/blogs/healthcare Table of Content of Global Radiation Oncology Market Research Report: Chapter 1. Methodology and Scope 1.1. Information Procurement 1.1.1. Purchased Database 1.1.2. GVR’s Internal Database 1.2. Data Analysis 1.3. Market Formulation & Validation 1.4. Approaches for Market Estimation 1.4.1. Approach 1: Commodity Flow & Bottom Up Approach 1.4.2. Approach 2: Top Down and Parent Market Analysis Chapter 2. Executive Summary 2.1. Market Snapshot Chapter 3. Radiation Oncology Market Variables, Trends & Scope 3.1. Market Segmentation & Scope 3.2. Market Size and Growth Prospects 3.3. Market Driver Analysis 3.3.1. Rising adoption of radiotherapy as first line of treatment 3.3.2. Technological advancements in radiation oncology 3.4. Market Restraint Analysis 3.4.1. Shortage of trained radiation oncologists 3.4.2. Lack of adequate infrastructure in developing regions

Follow Us:

3.5. Penetration & Growth Prospect Mapping 3.6. SWOT Analysis, by Factor 3.6.1. Political 3.6.2. Economic 3.6.3. Technological 3.7. Industry Analysis - Porter’s Chapter 4. Radiation Oncology: Product Estimates & Trend Analysis 4.1. Radiation Oncology Market Share, 2016 & 2025 4.2. Market Size, Estimates & Forecasts and Trend Analyses, 2014 to 2025 for the following products: 4.2.1. External Beam Radiation Therapy 4.2.1.1. External beam radiation therapy market estimates and forecasts, 2014 - 2025 4.2.1.2. Electron-Emitting High-Energy Linear Accelerators (Linac) 4.2.1.2.1. Electron-Emitting High-Energy Linear Accelerators (Linac) market estimates and forecasts, 2014 - 2025 4.2.1.3. Compact Advanced Radiotherapy Systems 4.2.1.3.1. Compact advanced radiotherapy systems market estimates and forecasts, 2014 - 2025 4.2.1.3.2. CyberKnife 4.2.1.3.2.1. CyberKnife market estimates and forecasts, 2014 2025 4.2.1.3.3. Gamma Knife 4.2.1.3.3.1. Gamma Knife market estimates and forecasts, 2014 2025 4.2.1.3.4. Tomotherapy 4.2.1.3.4.1. Tomotherapy market estimates and forecasts, 2014 -

Follow Us:

2025 4.2.1.4. Proton Therapy 4.2.1.4.1. Proton therapy market estimates and forecasts, 2014 2025 4.2.1.4.2. Cyclotron 4.2.1.4.2.1. Cyclotron market estimates and forecasts, 2014 2025 4.2.1.4.3. Synchrotron 4.2.1.4.3.1. Synchrotron market estimates and forecasts, 2014 2025 4.2.2. Brachytherapy 4.2.2.1. Brachytherapy market estimates and forecasts, 2014 - 2025 4.2.2.2. Seeds 4.2.2.2.1. Seeds market estimates and forecasts, 2014 - 2025 4.2.2.3. Applicators and Afterloaders 4.2.2.3.1. Applicators and Afterloaders market estimates and forecasts, 2014 - 2025 4.2.2.4. Electronic Brachytherapy 4.2.2.4.1. Electronic brachytherapy market estimates and forecasts, 2014 - 2025 4.2.3. Systemic Beam Radiation Therapy 4.2.3.1. Systemic beam radiation therapy market estimates and forecasts, 2014 - 2025 4.2.4. Other 4.2.4.1. Other radiation oncology market estimates and forecasts, 2014 - 2025 Chapter 5. Radiation Oncology: Application Estimates & Trend Analysis

Follow Us:

5.1. Radiation Oncology Market Share, 2016 & 2025 5.2. Market Size, Estimates & Forecasts and Trend Analyses, 2014 to 2025 for the following applications: 5.2.1. External Beam Radiation Therapy 5.2.1.1. External beam radiation therapy market estimates and forecasts, 2014 - 2025 5.2.1.2. Prostate Cancer 5.2.1.2.1. Prostate cancer market estimates and forecasts, 2014 2025 5.2.1.3. Breast Cancer 5.2.1.3.1. Breast cancer market estimates and forecasts, 2014 2025 5.2.1.4. Lung Cancer 5.2.1.4.1. Lung cancer market estimates and forecasts, 2014 - 2025 5.2.1.5. Head and Neck Cancer 5.2.1.5.1. Head and neck cancer market estimates and forecasts, 2014 - 2025 5.2.1.6. Colorectal Cancer 5.2.1.6.1. Colorectal cancer market estimates and forecasts, 2014 2025 5.2.1.7. Others 5.2.1.7.1. Other cancer market estimates and forecasts, 2014 - 2025 5.2.2. Internal Beam Radiation Therapy 5.2.2.1. Internal beam radiation therapy market estimates and forecasts, 2014 - 2025 5.2.2.2. Prostate Cancer 5.2.2.2.1. Prostate cancer market estimates and forecasts, 2014 -

Follow Us:

2025 5.2.2.3. Gynecological Cancer 5.2.2.3.1. Gynecological cancer market estimates and forecasts, 2014 - 2025 5.2.2.4. Breast Cancer 5.2.2.4.1. Breast cancer market estimates and forecasts, 2014 2025 5.2.2.5. Cervical Cancer 5.2.2.6. Penile cancer market estimates and forecasts, 2014 2025Penile Cancer 5.2.2.6.1. Prostate cancer market estimates and forecasts, 2014 2025 5.2.2.7. Other Cancer 5.2.2.7.1. Other cancer market estimates and forecasts, 2014 - 2025 Chapter 6. Radiation Oncology: Technology Estimates & Trend Analysis 6.1. Radiation Oncology Market Share, 2016 & 2025 6.2. Market Size, Estimates & Forecasts and Trend Analyses, 2014 to 2025 for the following technology: 6.2.1. External Beam Radiation Therapy 6.2.1.1. External beam radiation therapy market estimates and forecasts, 2014 - 2025 6.2.1.2. Image-Guided Radiotherapy (IGRT) 6.2.1.2.1. IGRT market estimates and forecasts, 2014 - 2025 6.2.1.3. Intensity Modulated Radiotherapy (IMRT) 6.2.1.3.1. IMRT market estimates and forecasts, 2014 - 2025 6.2.1.4. Stereotactic Technology 6.2.1.4.1. Stereotactic technology market estimates and forecasts,

Follow Us:

2014 - 2025 6.2.1.5. Proton Beam Therapy 6.2.1.5.1. Proton beam therapy market estimates and forecasts, 2014 - 2025 6.2.1.6. 3D Conformal Radiotherapy (3D CRT) 6.2.1.6.1. 3D CRT market estimates and forecasts, 2014 - 2025 6.2.1.7. Volumetric Modulated Arc Therapy (VMAT) 6.2.1.7.1. VMAT market estimates and forecasts, 2014 - 2025 6.2.2. Brachytherapy 6.2.2.1. Brachytherapy market estimates and forecasts, 2014 - 2025 6.2.2.2. Low-Dose Rate Radiotherapy 6.2.2.2.1. Low-Dose rate radiotherapy market estimates and forecasts, 2014 - 2025 6.2.2.3. High-Dose Rate Radiotherapy 6.2.2.3.1. How-Dose rate radiotherapy market estimates and forecasts, 2014 - 2025 Chapter 7. Radiation Oncology: Regional Estimates & Trend Analysis 7.1. Radiation Oncology Regional Movement Analysis & Market Share, 2016 & 2025 7.2. North America 7.2.1. U.S. 7.2.1.1. U.S. revenue estimates and forecasts by, product, 2014 - 2025 (USD Million) 7.2.1.2. U.S. revenue estimates and forecasts by, application, 2014 2025 (USD Million) 7.2.1.3. U.S. revenue estimates and forecasts by, technology, 2014 2025 (USD Million)

Follow Us:

7.2.2. Canada 7.2.2.1. Canada revenue estimates and forecasts by, product, 2014 2025 (USD Million) 7.2.2.2. Canada revenue estimates and forecasts by, application, 2014 - 2025 (USD Million) 7.2.2.3. Canada revenue estimates and forecasts by, technology, 2014 - 2025 (USD Million) 7.3. Europe 7.3.1. UK 7.3.1.1. UK revenue estimates and forecasts by, product, 2014 - 2025 (USD Million) 7.3.1.2. UK revenue estimates and forecasts by, application, 2014 2025 (USD Million) 7.3.1.3. UK revenue estimates and forecasts by, technology, 2014 2025 (USD Million) 7.3.2. Germany 7.3.2.1. Germany revenue estimates and forecasts by, product, 2014 2025 (USD Million) 7.3.2.2. Germany revenue estimates and forecasts by, application, 2014 - 2025 (USD Million) 7.3.2.3. Germany revenue estimates and forecasts by, technology, 2014 - 2025 (USD Million) 7.4. Asia Pacific 7.4.1. Japan 7.4.1.1. Japan revenue estimates and forecasts by, product, 2014 2025 (USD Million) 7.4.1.2. Japan revenue estimates and forecasts by, application, 2014 -

Follow Us:

2025 (USD Million) 7.4.1.3. Japan revenue estimates and forecasts by, technology, 2014 2025 (USD Million) 7.4.2. China 7.4.2.1. China revenue estimates and forecasts by, product, 2014 2025 (USD Million) 7.4.2.2. China revenue estimates and forecasts by, application, 2014 2025 (USD Million) 7.4.2.3. China revenue estimates and forecasts by, technology, 2014 2025 (USD Million) 7.5. Latin America 7.5.1. Brazil 7.5.1.1. Brazil revenue estimates and forecasts by, product, 2014 2025 (USD Million) 7.5.1.2. Brazil revenue estimates and forecasts by, application, 2014 2025 (USD Million) 7.5.1.3. Brazil revenue estimates and forecasts by, technology, 2014 2025 (USD Million) 7.5.2. Mexico 7.5.2.1. Mexico revenue estimates and forecasts by, product, 2014 2025 (USD Million) 7.5.2.2. Mexico revenue estimates and forecasts by, application, 2014 2025 (USD Million) 7.5.2.3. Mexico revenue estimates and forecasts by, technology, 2014 - 2025 (USD Million) 7.6. MEA 7.6.1. South Africa

Follow Us:

7.6.1.1. South Africa revenue estimates and forecasts by, product, 2014 - 2025 (USD Million) 7.6.1.2. South Africa revenue estimates and forecasts by, application, 2014 - 2025 (USD Million) 7.6.1.3. South Africa revenue estimates and forecasts by, technology, 2014 - 2025 (USD Million) Chapter 8. Competitive Landscape 8.1. Strategy Framework 8.2. Company Profiles 8.2.1. Varian Medical Systems 8.2.1.1. Company overview 8.2.1.2. Financial performance 8.2.1.3. Product benchmarking 8.2.1.4. Strategic initiatives 8.2.2. Elekta AB 8.2.2.1. Company overview 8.2.2.2. Financial performance 8.2.2.3. Product benchmarking 8.2.2.4. Strategic initiatives 8.2.3. Accuray Incorporated 8.2.3.1. Company overview 8.2.3.2. Financial performance 8.2.3.3. Product benchmarking 8.2.3.4. Strategic initiatives 8.2.4. Ion Beam Applications SA 8.2.4.1. Company overview 8.2.4.2. Financial performance

Follow Us:

8.2.4.3. Product benchmarking 8.2.4.4. Strategic initiatives 8.2.5. C.R. Bard, Inc. 8.2.5.1. Company overview 8.2.5.2. Financial performance 8.2.5.3. Product benchmarking 8.2.5.4. Strategic initiatives 8.2.6. Isoray Medical, Inc. 8.2.6.1. Company overview 8.2.6.2. Financial performance 8.2.6.3. Product benchmarking 8.2.6.4. Strategic initiatives 8.2.7. Mevion Medical Systems, Inc. 8.2.7.1. Company overview 8.2.7.2. Financial performance 8.2.7.3. Product benchmarking 8.2.7.4. Strategic initiatives 8.2.8. Nordian Inc. 8.2.8.1. Company overview 8.2.8.2. Financial performance 8.2.8.3. Product benchmarking 8.2.8.4. Strategic initiatives 8.2.9. NTP Radioisotopes 8.2.9.1. Company overview 8.2.9.2. Financial performance 8.2.9.3. Product benchmarking 8.2.9.4. Strategic initiatives

Follow Us:

8.2.10. Mallinckrodt Public Limited Company 8.2.10.1. Company overview 8.2.10.2. Financial performance 8.2.10.3. Product benchmarking 8.2.10.4. Strategic initiatives About Grand View Research, Inc.:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: sales@grandviewresearch.com For More Information: http://www.grandviewresearch.com

Follow Us: